These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 33375962)

  • 1. Myeloid-derived suppressor cell and regulatory T cell frequencies in canine myasthenia gravis: A pilot study.
    Wu Y; Chang YM; Lawson BS; Galban EM; Mittelman NS; Benedicenti L; Petesch SC; Carroll AB; Punt JA; Luo J; Garden OA
    Vet J; 2021 Jan; 267():105581. PubMed ID: 33375962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibody to acetylcholine receptor in canine and human myasthenia gravis: differential cross-reactivity with human and rabbit receptor.
    Dau PC; Yano CS; Ettinger SJ
    Neurology; 1979 Jul; 29(7):1065-8. PubMed ID: 572937
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autoimmunity in spontaneous myasthenia gravis in dogs.
    Garlepp MJ; Kay PH; Farrow BR; Dawkins RL
    Clin Immunol Immunopathol; 1984 May; 31(2):301-6. PubMed ID: 6325059
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibodies to the acetylcholine receptor in myasthenic dogs.
    Garlepp M; Farrow B; Kay P; Dawkins RL
    Immunology; 1979 Aug; 37(4):807-10. PubMed ID: 500127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adult onset acquired myasthenia gravis in three Great Dane littermates.
    Kent M; Glass EN; Acierno M; Shelton GD
    J Small Anim Pract; 2008 Dec; 49(12):647-50. PubMed ID: 18684140
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of suppressor cells specific for AChR in experimental autoimmune myasthenia gravis.
    McIntosh KR; Drachman DB
    Science; 1986 Apr; 232(4748):401-3. PubMed ID: 2938256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunosuppression in Dogs During Mammary Cancer Development.
    Mucha J; Rybicka A; Dolka I; Szymańska J; Manuali E; Parzeniecka-Jaworska M; Kluciński W; Król M
    Vet Pathol; 2016 Nov; 53(6):1147-1153. PubMed ID: 27106740
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduction in peripheral regulatory T cell population in childhood ocular type myasthenia gravis.
    Nishimura T; Inaba Y; Nakazawa Y; Omata T; Akasaka M; Shirai I; Ichikawa M
    Brain Dev; 2015 Sep; 37(8):808-16. PubMed ID: 25563663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autoimmune form of myasthenia gravis in a juvenile Yorkshire Terrier x Jack Russell Terrier hybrid contrasted with congenital (non-autoimmune) myasthenia gravis of the Jack Russell.
    Palmer AC; Lennon VA; Beadle C; Goodyear JV
    J Small Anim Pract; 1980 Jun; 21(6):359-64. PubMed ID: 7431884
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical forms of acquired myasthenia gravis in dogs: 25 cases (1988-1995).
    Dewey CW; Bailey CS; Shelton GD; Kass PH; Cardinet GH
    J Vet Intern Med; 1997; 11(2):50-7. PubMed ID: 9127290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Titin and ryanodine receptor autoantibodies in dogs with thymoma and late-onset myasthenia gravis.
    Shelton GD; Skeie GO; Kass PH; Aarli JA
    Vet Immunol Immunopathol; 2001 Jan; 78(1):97-105. PubMed ID: 11182151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inherited predisposition to myasthenia gravis in Newfoundlands.
    Lipsitz D; Berry JL; Shelton GD
    J Am Vet Med Assoc; 1999 Oct; 215(7):956-8, 946. PubMed ID: 10511859
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myeloid-derived suppressor cells as a potential therapy for experimental autoimmune myasthenia gravis.
    Li Y; Tu Z; Qian S; Fung JJ; Markowitz SD; Kusner LL; Kaminski HJ; Lu L; Lin F
    J Immunol; 2014 Sep; 193(5):2127-34. PubMed ID: 25057008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Possible therapeutic vaccines for canine myasthenia gravis: implications for the human disease and associated fatigue.
    Galin FS; Chrisman CL; Cook JR; Xu L; Jackson PL; Noerager BD; Weathington NM; Blalock JE
    Brain Behav Immun; 2007 Mar; 21(3):323-31. PubMed ID: 17113748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acquired myasthenia gravis: what we have learned from experimental and spontaneous animal models.
    Shelton GD
    Vet Immunol Immunopathol; 1999 Aug; 69(2-4):239-49. PubMed ID: 10507309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Megaoesophagus secondary to acquired myasthenia gravis.
    Yam PS; Shelton GD; Simpson JW
    J Small Anim Pract; 1996 Apr; 37(4):179-83. PubMed ID: 8731405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mitogen stimulation of canine normal and myasthenia gravis lymphocytes.
    Shelton GD; Fujii Y; Lindstrom J
    Vet Immunol Immunopathol; 1990 Jan; 24(1):1-9. PubMed ID: 2316185
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spontaneous remission in canine myasthenia gravis: implications for assessing human MG therapies.
    Shelton GD; Lindstrom JM
    Neurology; 2001 Dec; 57(11):2139-41. PubMed ID: 11739846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of peripheral blood B cell subset ratios and B cell-related cytokine levels between ocular and generalized myasthenia gravis.
    Hu Y; Wang J; Rao J; Xu X; Cheng Y; Yan L; Wu Y; Wu N; Wu X
    Int Immunopharmacol; 2020 Mar; 80():106130. PubMed ID: 31978800
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulatory T Cells and Myeloid-Derived Suppressor Cells in Patients with Peptic Ulcer and Gastric Cancer.
    Mesali H; Ajami A; Hussein-Nattaj H; Rafiei A; Rajabian Z; Asgarian-Omran H; Hosseini V; Taghvaei T; Tehrani M
    Iran J Immunol; 2016 Sep; 13(3):167-77. PubMed ID: 27671508
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.